See today's BioWorld
To read the full story, subscribe or sign in.

Gan & Lee planning $227M IPO in China; funds for innovation, global expansion

June 15, 2016
By Pearl Liu and Bonnie Wang
HONG KONG – Three years after a failed attempt, Chinese insulin maker Gan & Lee Pharmaceuticals Ltd. is looking at China's stock markets.
BioWorld